Prion disease: clinical pathway development for the terminally ill.

Autor: Hogg R; Palliative Medicine, Health Education Thames Valley - HETV, Oxford, UK r.hogg1@nhs.net.; Palliative Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Centola J; Neurology, National CJD Research and Surveillance Unit, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK., Durley K; Palliative Medicine, Health Education Thames Valley - HETV, Oxford, UK., Chin CA; Palliative Medicine, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Quibell R; Palliative Medicine, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK., Spriggs H; Health Education North East, Newcastle upon Tyne, England, UK., Carey M; Palliative Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.; Palliative Medicine, Sir Michael Sobell House Hospice, Oxford, UK., Bajorek T; Psychological Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Miller M; Palliative Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Bradley V; Palliative Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Pal S; Neurology, National CJD Research and Surveillance Unit, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.

Publikováno v: BMJ supportive & palliative care [BMJ Support Palliat Care] 2022 Oct 14. Date of Electronic Publication: 2022 Oct 14.